Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase NA 2Phase 1/2 1Phase 1 1

Status

Unknown 2Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 8Other hematologic neoplasm 5Plasma cell 4Thoracic 3Gastrointestinal 3Tumor-Agnostic 1Myeloid 1Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm, Residual 2Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 414Cytarabine 336fludarabine phosphate 231Rituximab 206Methotrexate 198fludarabine 196venetoclax 174Azacitidine 174Busulfan 169Filgrastim 145Whole-Body Irradiation 143Mycophenolic Acid 143Peripheral Blood Stem Cell Transplantation 141Tacrolimus 138Etoposide 130Vincristine 112Melphalan 110Dexamethasone 109Cyclosporine 102Granulocyte Colony-Stimulating Factor 100Imatinib Mesylate 94Antilymphocyte Serum 91Daunorubicin 90Radiotherapy 84Decitabine 83Dasatinib 76Lenalidomide 75Doxorubicin 70Prednisone 69Idarubicin 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Maintenance × Other hematologic neoplasm × Clear all
NCT07572929 2026-05-07

PREeMPT

Medical College of Wisconsin

Phase 2 Not yet recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06773936 2026-05-06

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

SWOG Cancer Research Network

Phase 2 Enrolling by invitation
55 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05827549 2025-06-06

ReCALL

Asan Medical Center

Phase 2 Recruiting
90 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02396043 2023-06-18

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Sun Yat-sen University

Phase 2 Unknown
50 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01665001 2012-08-17

Personalized Therapy of Precursor Lymphoid Neoplasms

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice

Phase 2 Unknown
200 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡